Competition law has again worked to fight a bad drug patent, but we need other solutions

A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.

Read More

Opinion: Engaging communities and young people in the HIV response

The AIDS2022 conference held recently in Montreal, Canada highlighted yet again the need for community activism and the importance of involving young people, writes Dr Yogan Pillay. He argues that the youth and communities must be engaged in the conceptualisation and writing of South Africa’s new AIDS plan, and young people and community-based organisations must have a central role in key aspects of its implementation.

Read More

OPINION: Fix our clinics, save our lives

We are not making a flippant statement or trying to cry wolf, but we have a crisis in our health system which will have a devastating impact if not addressed, writes three people involved with the new Ritshidze clinic monitoring initiative.

Read More